50 Innovative Emerging Medical Technology Companies Seeking Funding and/or Strategic Partnership to Present at Medtech Insight's 'In3 WEST' Investment and Partnering Conference; Feb. 23-24, 2006, Irvine, Calif.

NEWPORT BEACH, Calif. -- Medtech Insight and Windhover Information have announced that 24 early-stage companies to date have been confirmed to present, out of the 50 that will present in total, at their upcoming "Investment In Innovation (In3) WEST: A Preview of Early-Stage Medical Technology Companies" conference, being held Feb. 23-24, 2006, at the Hyatt Regency Irvine in Irvine. This large group of companies will present to a focused audience of senior executives representing most of the major investment and medical technology firms, for purposes of funding and/or strategic partnership. Products under development that will be highlighted at the event include novel tissue engineering, orthopedics and spine, percutaneous heart valve and other cardiovascular, intraocular lens (IOL), stroke treatment, wound healing, drug delivery, and brain imaging technologies, among many others. In3 WEST is Medtech Insight's 20th investment and partnering conference to date.

Presenting companies confirmed thus far include (most presenting at a Medtech Insight event for the first time; many more being added): ACell, AerovectRx, AION Diagnostics, Biosan Medical, Cardiovascular Systems, CleveX, CVAC Systems, Cytograft Tissue Engineering, Design Medical, EndoCor, Gluco Stats System, HemoBioTech, InfraScan, InnerVision Medical Technologies, IYIA Technologies, Lingualcare, MedicalCV, Novomedica, OtisMed, Paradigm Spine, PhotoImmune Biotechnology, Tekia, VasoGenix Pharmaceuticals, and Vision Solutions Technologies, among many others being confirmed regularly. See the Medtech Insight Web site for event details: http://www.medtechinsight.com/in3-16.html.

In3 WEST will also feature tabletop exhibits and product prototypes by presenting companies during a networking dinner, and a keynote presentation by Michael Henson, General Partner at MedFocus Fund and founder/CEO/Chairman/Board Member of 16 emerging healthcare companies titled "From Invention to Commercialization ... and Beyond." Scott Wolf, M.D., Partner at Prospect Venture Partners and founder of Percardia, Cardiac Dimensions, Archus Orthopedics and Endogastric Solutions, will give the "State of Medtech Investing - 2006" presentation. In3 WEST will also feature an informative, interactive panel discussion titled "The Big Company Perspective on Deal-Making." The high-powered panel, moderated by David Cassak, Managing Partner at Windhover Information, will feature a number of prominent industry decision makers (to be announced).

Medtech Insight's conferences have drawn over 5,600 attendees and over 630 innovative early-stage presenting companies over the past five years, making them the premier investment, partnering, and networking event in the medical technology industry. To register to attend or if your emerging company is interested in presenting, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., e-mail [e-mail], or visit www.medtechinsight.com. Through Jan. 23, 2006, attendees registering for the conference can save $200 off the $1,495 registration fee.

About Medtech Insight

Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, and to see the company's 2006 conference schedule, please visit www.medtechinsight.com.